Roche has taken the Trump pledge, joining Pfizer, Novartis and Merck in promising to hold the line on drug prices
You can add yet another Big Pharma to the growing list of giants swearing off US price hikes.
Roche tells me this morning that they told HHS on July 11 — the day after Pfizer CEO Ian Read agreed to roll back a price hike in a call with the president — that “we will not be taking any price increases for the remainder of the year.”
Roche’s move comes as Pfizer, Novartis and Merck have all pledged to hold the line on drug prices for the rest of the year — which comes amid considerable skepticism over just how meaningful this is. And Reuters is reporting that Bayer and Merck KGaA are also falling into line.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.